Alzai Health Corp. (TSXV:ALZI)
0.3700
0.00 (0.00%)
Sep 18, 2026, 3:23 PM EST
Alzai Health Market Cap
Alzai Health has a market cap or net worth of CAD 23.97 million as of September 18, 2026.
Market Cap
23.97M
Enterprise Value
24.54M
Revenue
27.04K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.37
ChartMarket Cap Chart
Since June 9, 2026, Alzai Health's market cap has decreased from 26.94M to 23.97M, a decrease of -11.02%. That is a compound annual growth rate of -34.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 23.97M | - |
| Sep 11, 2026 | 23.97M | 1.37% |
| Sep 8, 2026 | 23.65M | -1.35% |
| Sep 2, 2026 | 23.97M | -1.33% |
| Sep 1, 2026 | 24.30M | 1.01% |
| Aug 26, 2026 | 24.06M | 19.05% |
| Aug 25, 2026 | 20.21M | -4.55% |
| Aug 21, 2026 | 21.17M | 10.00% |
| Aug 20, 2026 | 19.24M | -1.64% |
| Aug 19, 2026 | 19.57M | -14.08% |
| Aug 12, 2026 | 22.77M | - |
| Aug 11, 2026 | 22.77M | - |
| Aug 6, 2026 | 22.77M | -1.39% |
| Jul 30, 2026 | 23.09M | -5.26% |
| Jul 29, 2026 | 24.38M | -2.56% |
| Jul 17, 2026 | 25.02M | -11.36% |
| Jul 13, 2026 | 28.22M | -6.38% |
| Jul 10, 2026 | 30.15M | 17.50% |
| Jul 9, 2026 | 25.66M | -6.98% |
| Jul 8, 2026 | 27.58M | -4.44% |
| Jul 7, 2026 | 28.87M | - |
| Jul 3, 2026 | 28.87M | -4.26% |
| Jun 30, 2026 | 30.15M | 4.44% |
| Jun 29, 2026 | 28.87M | -10.00% |
| Jun 25, 2026 | 32.07M | 6.38% |
| Jun 24, 2026 | 30.15M | -6.00% |
| Jun 22, 2026 | 32.07M | 4.17% |
| Jun 19, 2026 | 30.79M | - |
| Jun 16, 2026 | 30.79M | 6.67% |
| Jun 10, 2026 | 28.87M | 7.14% |
| Jun 9, 2026 | 26.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medicenna Therapeutics | 39.23M |
| Telescope Innovations | 37.18M |
| Defence Therapeutics | 37.14M |
| Thiogenesis Therapeutics | 35.69M |
| Resverlogix | 30.99M |
| The More Life Company | 29.71M |
| Pharmala Biotech Holdings | 29.07M |
| Onco-Innovations | 27.32M |